India’s Serum Institute overpromises and underdelivers as Covid death toll mounts The Serum Institute of India’s travails are a key illustration of how the effort to inoculate against Covid-19 has failed the developing world 09 June 2021 - 16:04 Chris Kay and PR Sanjai Picture: REUTERS/DINUKA LIYANAWATTE
London/New Delhi Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots have been grappling with stalled Covid-19 vaccination programmes as they run out of doses. Many of those shortages can be traced back to a single company: The Serum Institute of India.
The world’s largest vaccine maker, Serum was named a top supplier of Covid-19 shots to Covax in 2020, the World Health Organisation-backed initiative aimed at securing an equitable global rollout. But the Indian company has been dogged by setbacks, from a ban on exports to a factory fire, which have hampered its ability to fill orders.
New Delhi [India], June 6 (ANI): A New Delhi-based think tank Law and Society Alliance organised a webinar on ongoing issues concerning Tibet and China's "attempts" to destroy the institution of the Dalai Lama.
A New Delhi-based think tank Law and Society Alliance organised a webinar on ongoing issues concerning Tibet and China attempts to destroy the institution o
Reliance Brands is set to take over fashion house Ritu Kumar, said three people familiar with the development. The Reliance Retail unit will pick up the stake of about 30% held by private equity firm Everstone Capital and a big chunk of the promoters holdings.